Celsion (CLSN) Reaches $2.42 After 3.00% Up Move; Westrock Company (WRK) Sellers Decreased By 21.86% Their Shorts

December 6, 2017 - By Michael Collier

Westrock Company (NYSE:WRK) had a decrease of 21.86% in short interest. WRK’s SI was 2.18 million shares in December as released by FINRA. Its down 21.86% from 2.78M shares previously. With 1.68 million avg volume, 1 days are for Westrock Company (NYSE:WRK)’s short sellers to cover WRK’s short positions. The SI to Westrock Company’s float is 0.91%. The stock decreased 0.24% or $0.15 during the last trading session, reaching $63.16. About 195,539 shares traded. WestRock Company (NYSE:WRK) has risen 40.51% since December 6, 2016 and is uptrending. It has outperformed by 23.81% the S&P500.

The stock of Celsion Corporation (NASDAQ:CLSN) is a huge mover today! The stock increased 1.02% or $0.024 during the last trading session, reaching $2.424. About 176,578 shares traded. Celsion Corporation (NASDAQ:CLSN) has declined 82.71% since December 6, 2016 and is downtrending. It has underperformed by 99.41% the S&P500.The move comes after 7 months positive chart setup for the $38.94M company. It was reported on Dec, 6 by Barchart.com. We have $2.50 PT which if reached, will make NASDAQ:CLSN worth $1.17 million more.

Celsion Corporation, an oncology drug company, focuses on the development and commercialization of directed chemotherapy, DNA-mediated immunotherapy, and RNA based therapy products for the treatment of cancer. The company has market cap of $38.94 million. The companyÂ’s lead product includes ThermoDox, a liposomal encapsulation of doxorubicin that is in Phase III clinical trials for primary liver cancer; and under Phase II clinical trials for recurrent chest wall breast cancer. It currently has negative earnings. It is also developing GEN-1, a DNA immunotherapeutic product for the localized treatment of ovarian and brain cancers.

Among 2 analysts covering Celsion (NASDAQ:CLSN), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Celsion had 9 analyst reports since August 7, 2015 according to SRatingsIntel. The company was maintained on Tuesday, January 19 by Maxim Group. The firm has “Hold” rating by Maxim Group given on Monday, August 7. The rating was maintained by Maxim Group on Tuesday, August 15 with “Hold”. The stock of Celsion Corporation (NASDAQ:CLSN) earned “Hold” rating by Zacks on Wednesday, August 12. The firm has “Buy” rating given on Monday, November 20 by Oppenheimer. The rating was downgraded by Maxim Group on Thursday, November 10 to “Hold”. The stock of Celsion Corporation (NASDAQ:CLSN) earned “Buy” rating by Cantor Fitzgerald on Friday, August 7. Maxim Group upgraded Celsion Corporation (NASDAQ:CLSN) on Thursday, October 5 to “Buy” rating. The firm has “Hold” rating by Maxim Group given on Thursday, June 1.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.